BSG and urinary bladder cancer: Fixed-effects model showed a higher rate of CD147 expression in the bladder cancer group (OR=59.50, 95% CI=[13.75, 257.42], P<0.00001), without heterogeneity (P=0.94, I2 =0%) (Figure 3D).